Company intelligence / Profile preview
Sundance Biosciences
South San Francisco, CA, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Sundance Biosciences is a clinical-stage biotechnology company focused on developing next-generation immune modulators. Spun out from Neuron23 in late 2025, the company is advancing a pipeline of three oral small molecule therapies targeting TYK2, a key enzyme in immune system regulation. Its lead programs include SUN-627, a brain-penetrant TYK2 inhibitor for multiple sclerosis and neuroinflammation, and SUN-111, a peripherally-restricted inhibitor for immunology indications. Both lead candidates have completed Phase 1 clinical trials, demonstrating strong target engagement and safety profiles. Sundance is led by an experienced management team and backed by prominent investors including Westlake BioPartners and Blue Owl.
- Therapeutic areas
- NeurologyImmunology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Sundance Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sundance Biosciences.